Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2016 08:00 ET | Source: Phrixus Pharmaceuticals, Inc.

FDA allows Phrixus’s IND for Carmeseal-MD™ (P-188 NF) in Duchenne muscular dystrophy (DMD)

ANN ARBOR, Mich., Sept. 07, 2016 (GLOBE NEWSWIRE) -- Phrixus Pharmaceuticals is announcing that FDA allowed Phrixus’s IND for Carmeseal-MD (P-188 NF) in Duchenne muscular dystrophy (DMD). The...